Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03572426 · ClinicalTrials.gov registry record
Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 164
- Enrollment target
NCT03572426 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 164 participants.
The verdict
NCT03572426 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
Genotype 164 adults to evaluate six selected single nucleotide polymorphisms (SNPs) (rs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582) for use as a genetic biomarker to differentiate between bipolar depression and unipolar depression.
Interventions
- OTHER genotyping all subjects
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2019-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03572426
The ClinicalTrials.gov registry entry for NCT03572426 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which genotyping all subjects is the first listed.
NCT03572426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03572426 about?
NCT03572426 is a clinical study titled "Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder". Genotype 164 adults to evaluate six selected single nucleotide polymorphisms (SNPs) (rs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582) for use as a genetic biomarker to differentiate between bipolar depression and unipolar depression.
What is the current status of trial NCT03572426?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2018-06-13. Estimated completion is 2019-04-04.
What interventions are being tested in trial NCT03572426?
The interventions under investigation include: genotyping all subjects (OTHER).
Who is sponsoring clinical trial NCT03572426?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.